-

Diality Joins Kidney Care Partners

Diality and Kidney Care Partners committed to advancing innovation in kidney care

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company offering the Moda-flx Hemodialysis System™, today announced that it has joined Kidney Care Partners, the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers.

“Diality is proud to become a member of an organization like Kidney Care Partners,” said Dan Guthrie, Chief Business Officer at Diality. “Kidney Care Partners’ dedication to patient-centered care and innovation within kidney care is perfectly aligned with Diality’s mission of improving lives impacted by kidney disease. We look forward to contributing to Kidney Care Partners’ legislative agenda.”

“Kidney Care Partners is thrilled to welcome Diality, a hemodialysis innovator who brings an important voice to our coalition,” said Mahesh Krishnan, MD, MPH, MBA, Chair of Kidney Care Partners. “Together, we look forward to advancing initiatives that promote innovation and benefit patients across the kidney disease continuum.”

Diality is one of several members of Kidney Care Partners focused on innovation within kidney care, and the first pre-revenue medical device manufacturer among the new member organizations. Diality recently received 510(k) clearance for the Moda-flx Hemodialysis System.

About Diality

Diality is a medical device company focused on developing solutions to improve lives impacted by kidney disease. The Moda-flx Hemodialysis System is a user-friendly, mobile, and connected hemodialysis platform designed to maximize clinical flexibility by combining prescription capabilities of in-center systems with the ease-of-use of next generation hemodialysis devices. Moda-flx Hemodialysis system obtained U.S. FDA clearance in August 2024. Please visit www.diality.com or find us on LinkedIn to learn more about Diality and the Moda-flx Hemodialysis System.

About Kidney Care Partners

Kidney Care Partners (KCP) is a non-profit coalition of over 25 organizations, comprising patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers. KCP members are committed to meeting patients’ needs at every stage along the care continuum, and our diverse membership shares a broad vision of KCP policy priorities. These priorities range across the full spectrum of the disease cycle from education and prevention to early intervention to dialysis and, finally, to transplant and post-transplant care. Additional information about KCP’s legislative priorities is available here.

Contacts

Sam Choinski
Pazanga Health Communications
schoinski@pazangahealth.com
(860) 301-5058

Sarah Feagan
Schmidt Public Affairs
sfeagan@schmidtpa.com
(615) 560-2059

Diality


Release Versions

Contacts

Sam Choinski
Pazanga Health Communications
schoinski@pazangahealth.com
(860) 301-5058

Sarah Feagan
Schmidt Public Affairs
sfeagan@schmidtpa.com
(615) 560-2059

Social Media Profiles
More News From Diality

Diality Names Dr. Chris Springer to Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company that has developed the Moda-flx Hemodialysis System™, today announced the addition of Dr. Chris Springer to its board of directors. Dr. Springer brings 30 years of commercial and strategic experience in the pharmaceutical and biotech industries to Diality. As Chief Strategy Officer for Vifor Pharma, he created a joint renal-drug company between Vifor Pharmaceuticals and Fresenius Medical Care as well as oversaw a series of...

Diality Announces First Patient Treated With Moda-flx Hemodialysis System

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced successful completion of the first-ever patient treatment with the Moda-flx Hemodialysis System™ in collaboration with North America Research Institute at Ontario-Holt Dialysis Center in Ontario, Calif. “Our partnership with the North America Research Institute is an important step toward delivering on our promise to improve the lives of patients and families af...

Diality Receives FDA 510(k) Clearance for Its Moda-flx Hemodialysis System

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced that it has secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Moda-flx Hemodialysis System™. “Receiving 510(k) clinical clearance for Moda-flx is an incredible milestone in our mission of developing solutions to improve lives impacted by kidney disease,” said Osman Khawar, M.D., CEO of Diality. “We believe this platform will rep...
Back to Newsroom